Pancreas Cancer-Associated Polymyositis of the Legs Regressing After Cephalic Duodenopancreatectomy: Case Report and Review of the Literature
Abstract
Context Inflammatory myopathy, such as polymyositis, has been widely reported as paraneoplastic syndrome associated with various malignancies. However, its association with pancreas adenocarcinoma is very uncommon. Case report A case of a patient with paraneoplastic polymyositis of both legs associated with pancreatic adenocarcinoma is reported here. The diagnosis of polymyositis was highlighted by MRI and confirmed by histopathological examination. The surgical resection of the primary tumor led to the complete resolution of polymyositis with no further recurrence despite later metastases. Conclusion The association between pancreatic cancer and paraneoplastic polymyositis is very uncommon and has to be recognized by clinicians.
Image: MRI (T1) axial section of thigh with gadolinium injection.
Downloads
References
Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96–100.
Stockton D, Doherty VR, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001;85:41–5.
Kida Y, Maeshima E, Furukawa K, Ichikawa T, Goda M, Ichinose M. A case of polymyositis with a significantly high level of KL-6 associated with pancreatic cancer. Mod Rheumatol 2007;17:262–4.
Syrios J, Kechagias G, Xynos ID, Gamaletsou MN, Papageorgiou A, Agrogiannis G, et al. Pancreatic adenocarcinoma-associated polymyositis treated with corticosteroids along with cancer specific treatment: case report. BMC Gastroenterol 2011;11:33.
Aggarwal R, Oddis CV. Paraneoplastic myalgias and myositis. Rheum Dis Clin North Am 2011;37:607–21.
András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008;35:438–44.
Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003;362:971–82.
Rider LG, Miller FW. Idiopathic inflammatory muscle disease: clinical aspects. Baillieres Best Pract Res Clin Rheumatol 2000;14:37–54.
Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H, et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore) 2009;88:91–7.
Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 1989;20:224–31.
Pentsova E, Liu A, Rosenblum M, O'Reilly E, Chen X, Hormigo A. Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review. J Neurooncol 2012;106:15-21.
Ardavanis AS, Ioannidis GN, Rigatos GA. Acute Myopathy in a Patient with Lung Adenocarcinoma Treated with Gemcitabine and Docetaxel. Anticancer Res 2005;25:523-5.
Wong KM, Khanna M, Wu RC, Hedley DW. Gemcitabine-Induced Acute Myositis in a Patient with Duodenal Cancer. Clin Oncol 2011;23:492-3.
Airio A, Pukkala E, Isomäki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 1995;22:1300–3.
Bonnetblanc JM, Bernard P, Fayol J. Dermatomyositis and malignancy. A multicenter cooperative study. Dermatologica 1990;180:212–6.
Copyright (c) 2014 Koceila Lamine Amroun, Louis de Mestier, Sophie Deguelte-Lardiere, Marie-Danièle Diebold, Olivier Bouché, Reza Kianmanesh
This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.